Aldevron and Integrated DNA Technologies Manufacture World’s First mRNA-based Personalized CRISPR Therapy
Go back to Aldevron and Integrated DNA Technologies Manufacture World’s First mRNA-based Personalized CRISPR Therapy| Danaher Corp. (NYSE: DHR) | Delayed: 215.91 +4.41 (2.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $211.50 | 52 Week High | $102.79 | |||
| Open | $210.12 | 52 Week Low | $75.71 | |||
| Day High | $220.67 | P/E | 56.82 | |||
| Day Low | $208.21 | EPS | $3.80 | |||
| Volume | 5,503,178 | |||||
